학술논문
Comparative Real Life Egyptian Experience of the Combination of Sofosbuvir Plus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic Patients Infected with HCV Genotype 4
Document Type
Article
Author
Source
In: Current Drug Safety . (Current Drug Safety, May 2023, 18(2):207-213)
Subject
Language
English
ISSN
15748863